China approves first homegrown mRNA COVID-19 vaccine for emergency use

“China’s drugmaker CSPC Pharmaceutical Group Limited announced Wednesday that its messenger RNA (mRNA) COVID-19 vaccine has been approved for emergency use by the National Medical Products Administration, making it the country’s first domestically developed mRNA shot.”

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: